Pricing Log in Create free account

Citius Pharmaceuticals, Inc. (CTXR) vs SeaStar Medical Holding Corporation (ICU)

Citius Pharmaceuticals, Inc. and SeaStar Medical Holding Corporation are both Biotechnology companies. Citius Pharmaceuticals, Inc. and SeaStar Medical Holding Corporation are of similar size ($13.5M and $12.6M). Citius Pharmaceuticals, Inc. has the higher net margin (0.00% vs −795.5%) and the lower return on invested capital (−58.7% vs 0.00%). Across the 14 metrics below, Citius Pharmaceuticals, Inc. leads on 7 and SeaStar Medical Holding Corporation on 7.

Valuation

Metric CTXR ICU Biotechnology median
P/E n/m n/m 8.50
P/S n/m 6.99 9.71
P/B 0.16 2.79 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 4.42 9.21
Earnings yield (372.09%) (133.45%) (33.15%)
Free cash flow yield (289.71%) (114.43%) (25.50%)

Profitability

Metric CTXR ICU Biotechnology median
Gross margin 0.00% 92.64% 65.16%
Operating margin 0.00% (816.75%) 0.00%
Net margin 0.00% (795.50%) 0.00%
Free cash flow margin 0.00% (799.36%) 0.00%
Return on equity (64.51%) (356.87%) (56.36%)
Return on assets (34.29%) (160.02%) (48.04%)
Return on invested capital (58.74%) 0.00% 0.00%

Growth

Metric CTXR ICU Biotechnology median
Revenue growth (TTM) — 123.63% 6.02%
EPS growth (last fiscal year) 43.38% 91.16% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTXR ICU Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 0.84 1.89 4.72
Net debt to EBITDA 0.11 0.99 0.96

Dividend

Metric CTXR ICU Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CTXR ICU Biotechnology median
Market cap 12.63m 13.48m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack